Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China flag China · Delayed Price · Currency is CNY
12.02
-0.11 (-0.91%)
Nov 17, 2026, 3:00 PM CST

SHA:600161 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
700.141,0911,5491,110880.92760.01
Depreciation & Amortization
416.91416.91331.52268.02179.75157.15
Other Amortization
40.8240.8231.320.8112.398.38
Loss (Gain) From Sale of Assets
-0.1-0.1-0.040.05-15.63-0.51
Asset Writedown & Restructuring Costs
2.882.8853.591.212.115.09
Loss (Gain) From Sale of Investments
-29.4-29.4-63.93-37.21-28.13-12
Provision & Write-off of Bad Debts
62.1562.159.74-0.651.26-0.14
Other Operating Activities
1,113428.57572.18405.98327.41314.14
Change in Accounts Receivable
-1,376-1,376-473.121,029-221.05-351.21
Change in Inventory
-172.04-172.04-579.84-514.44-181.530.96
Change in Accounts Payable
-113.34-113.34-613.198.57167.4266.15
Operating Cash Flow
632.02338.75819.782,3941,126980.35
Operating Cash Flow Growth
--58.68%-65.75%112.57%14.86%39.63%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-619.41-605.53-1,067-1,078-1,354-1,132
Sale of Property, Plant & Equipment
0.260.340.160.310.718.51
Cash Acquisitions
---963.78-1.58-36.36-29.33
Divestitures
5.13-----
Investment in Securities
708.15694508.33-200--1,030
Other Investing Activities
-666.9135.55-336.4131.9-481.24-2.44
Investing Cash Flow
-572.78124.35-1,859-1,247-1,871-2,185

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-286.93----
Total Debt Issued
351.41286.93----
Long-Term Debt Repaid
--22.49-17.76-385.85-132.8-366.17
Lease Payments
-22.49-22.49-17.76-19.6-25.3-19.75
Net Debt Issued (Repaid)
328.93264.44-17.76-385.85-132.8-366.17
Issuance of Common Stock
-----3,332
Common Dividends Paid
-297.15-494.34-247.17-94.02-157.21-163.84
Other Financing Activities
-72.46-212.49-105.36-28.21-88.19-27.6
Financing Cash Flow
-40.68-442.4-370.29-508.08-378.22,774

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.06-0.03-0.04-0-0.05-0.01
Net Cash Flow
18.520.68-1,410638.58-1,1231,570

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
12.61-266.78-247.631,316-228.02-151.35
Free Cash Flow Growth
------
Free Cash Flow Margin
0.23%-4.32%-4.11%25.40%-5.35%-3.68%
Free Cash Flow Per Share
0.01-0.14-0.130.66-0.11-0.08
Levered Free Cash Flow
179.77-453.35-1,3361,047-348.46-470.29
Unlevered Free Cash Flow
183.05-448.76-1,3321,049-346.96-468.36
Free Cash Flow After Leases
-9.88-289.27-265.391,296-253.32-171.1

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
873.7767.13636.71582.34412.48386.75
Change in Working Capital
-1,674-1,674-1,664625.47-234.08-261.77